On June 9, 2022, Ensol Biosciences Inc. closed the transaction. The company has now received KRW 2,930,000,000 in the transaction. The conversion request period will start from June 09, 2023 to May 09, 2027.

The transaction included participation from Gluon Bond Investment Day for KRW 2,230,000,000, Yang, Ji-hee for KRW 300,000,000, Kim, In-suk for KRW 100,000,000, and other investors.